Table 2. Analysis of Glycated Hemoglobin A1c Goal Achievement Between Pharmacist‑Physician Managed Care and Usual Medical Care, Florida, 2017–2019.
| Goal Achievement | Pharmacist–Physician Managed |
Usual Medical Care |
P Value | ||
|---|---|---|---|---|---|
| Patients Who Met HbA1c Goal, No./Total | Time to HbA1c Goal, Median (95% CI), d | Patients Who Met HbA1c Goal, No./Total | Time to HbA1c Goal, Median (95% CI), d | ||
| Overall | 38/76 | 470 (372.0–NE) | 78/181 | 569 (437–707) | .60 |
| Cohort classification by baseline HbA1c | .11 | ||||
| Less than median (<8%) | 12/20 | 380 (224.0–NE) | 57/104 | 437 (383.0–638.0) | NA |
| Greater than or equal to median (≥8%) | 26/56 | 512 (372.0–NE) | 21/77 | 668 (612.0–NE) | NA |
| Stratification by adherence to visit schedule | .80 | ||||
| Low adherence | 8/24 | NE | 24/62 | 612 (424.0–NE) | NA |
| Moderate adherence | 19/30 | 441 (335.0–NE) | 25/54 | 457 (392.0–NE) | NA |
| High adherence | 11/22 | 381 (263.0–NE) | 29/65 | 569 (383.0–867.0) | NA |
Abbreviations: CI, confidence interval; HbA1c, glycated hemoglobin A1c; NA, not applicable; NE, not estimable.